Free Trial
NASDAQ:BFRI

Biofrontera (BFRI) Stock Price, News & Analysis

Biofrontera logo
$0.85 -0.01 (-1.63%)
As of 10:56 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Biofrontera Stock (NASDAQ:BFRI)

Key Stats

Today's Range
$0.86
$0.90
50-Day Range
$0.57
$0.86
52-Week Range
$0.54
$2.22
Volume
28,076 shs
Average Volume
949,520 shs
Market Capitalization
$7.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.75
Consensus Rating
Buy

Company Overview

Biofrontera Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
58th Percentile Overall Score

BFRI MarketRank™: 

Biofrontera scored higher than 58% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Biofrontera has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Biofrontera has only been the subject of 1 research reports in the past 90 days.

  • Read more about Biofrontera's stock forecast and price target.
  • Earnings Growth

    Earnings for Biofrontera are expected to grow in the coming year, from ($3.01) to ($0.55) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Biofrontera is -0.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Biofrontera is -0.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Biofrontera has a P/B Ratio of 1.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Biofrontera's valuation and earnings.
  • Percentage of Shares Shorted

    2.26% of the float of Biofrontera has been sold short.
  • Short Interest Ratio / Days to Cover

    Biofrontera has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biofrontera has recently decreased by 48.47%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Biofrontera does not currently pay a dividend.

  • Dividend Growth

    Biofrontera does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.26% of the float of Biofrontera has been sold short.
  • Short Interest Ratio / Days to Cover

    Biofrontera has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biofrontera has recently decreased by 48.47%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Biofrontera has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.01 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Biofrontera this week, compared to 1 article on an average week.
  • Search Interest

    Only 2 people have searched for BFRI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Biofrontera insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.20% of the stock of Biofrontera is held by insiders.

  • Percentage Held by Institutions

    Only 10.08% of the stock of Biofrontera is held by institutions.

  • Read more about Biofrontera's insider trading history.
Receive BFRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biofrontera and its competitors with MarketBeat's FREE daily newsletter.

BFRI Stock News Headlines

Q3 Earnings Estimate for Biofrontera Issued By Roth Capital
Refund From 1933: Trump’s Reset May Create Instant Wealth
Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real wealth for early adopters In 1933, Executive Order 6102 forced everyday Americans to hand over their gold at a fixed rate. Everyday citizens lost a sizable amount of their hard earned wealth at the stroke of FDR's pen.
See More Headlines

BFRI Stock Analysis - Frequently Asked Questions

Biofrontera's stock was trading at $1.09 on January 1st, 2025. Since then, BFRI shares have decreased by 21.1% and is now trading at $0.86.

Biofrontera Inc. (NASDAQ:BFRI) posted its earnings results on Thursday, May, 15th. The company reported ($0.47) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by $0.33. The firm earned $8.59 million during the quarter, compared to analyst estimates of $10.55 million. Biofrontera had a negative net margin of 30.33% and a negative trailing twelve-month return on equity of 305.13%.
Read the conference call transcript
.

Biofrontera shares reverse split on Wednesday, July 5th 2023.The 1-20 reverse split was announced on Wednesday, July 5th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 5th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Biofrontera (BFRI) raised $19 million in an initial public offering (IPO) on Friday, October 29th 2021. The company issued 3,100,000 shares at $5.00-$7.00 per share. Roth Capital Partners and The Benchmark Company acted as the underwriters for the IPO.

Shares of BFRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biofrontera investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), AST SpaceMobile (ASTS), NVIDIA (NVDA), NIO (NIO) and Meta Platforms (META).

Company Calendar

Last Earnings
5/15/2025
Today
7/13/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BFRI
CIK
1858685
Fax
N/A
Employees
70
Year Founded
N/A

Price Target and Rating

High Price Target
$2.75
Low Price Target
$2.75
Potential Upside/Downside
+219.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.26)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$17.76 million
Net Margins
-30.33%
Pretax Margin
-30.28%
Return on Equity
-305.13%
Return on Assets
-82.67%

Debt

Debt-to-Equity Ratio
8.99
Current Ratio
1.40
Quick Ratio
0.80

Sales & Book Value

Annual Sales
$37.32 million
Price / Sales
0.22
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.57 per share
Price / Book
1.51

Miscellaneous

Outstanding Shares
9,450,000
Free Float
9,333,000
Market Cap
$8.13 million
Optionable
No Data
Beta
0.43
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:BFRI) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners